Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:44:14 EDT Thu 27 Mar 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for U:OTLK from 2024-03-28 to 2025-03-27 - 33 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-02-28 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration
2025-02-19 09:00U:OTLKNews ReleaseOutlook Therapeutics(TM) Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference
2025-02-14 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Reports Financial Results for First Quarter Fiscal Year 2025 and Provides Corporate Update
2025-02-04 09:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Participates in Virtual Investor "What This Means" Segment
2025-01-31 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Appoints Faisal G. Sukhtian as Chairman of the Board of Directors
2025-01-23 09:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces Presentation of Efficacy and Safety Results from NORSE EIGHT Clinical Trial Evaluating ONS-5010 for the Treatment of Wet AMD
2025-01-22 09:05U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
2025-01-16 06:00U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial
2025-01-08 09:15U:OTLKNews ReleaseOutlook Therapeutics(TM) Participates in Virtual Investor "What This Means" Segment
2024-12-27 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update
2024-12-13 16:30U:OTLKNews ReleaseOutlook Therapeutics(TM) Streamlines Operations
2024-12-04 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces NICE Recommendation of LYTENAVA(TM) (bevacizumab gamma) for the Treatment of Wet AMD
2024-12-03 16:30U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces Executive Leadership Transition
2024-11-27 06:50U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces Preliminary Topline Results of NORSE EIGHT Clinical Trial
2024-11-06 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the Guggenheim Healthcare Innovation Conference
2024-10-17 09:00U:OTLKNews ReleaseOutlook Therapeutics(TM) Participates in a Virtual Investor CEO Connect Segment
2024-09-16 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) to Participate in the Virtual Investor Closing Bell Series
2024-09-13 09:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series
2024-09-04 08:35U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces Completion of Enrollment in NORSE EIGHT Clinical Trial
2024-09-03 08:45U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the H.C. Wainwright 26th Annual Global Investment Conference
2024-08-14 07:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update
2024-08-12 09:05U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
2024-08-07 08:35U:OTLKNews ReleaseOutlook Therapeutics(TM) to Report Financial Results for Third Quarter Fiscal Year 2024 on August 14, 2024 and Host Quarterly Conference Call and Webcast
2024-07-30 09:10U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the BTIG Virtual Biotechnology Conference 2024
2024-07-08 08:35U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces UK MHRA Marketing Authorization of LYTENAVA(TM) (bevacizumab gamma) for the Treatment of Wet AMD
2024-06-11 09:05U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the Virtual Investor Pitch Conference
2024-05-28 08:05U:OTLKNews ReleaseOutlook Therapeutics(TM) Receives European Commission Marketing Authorization for LYTENAVA(TM) (bevacizumab gamma) for the Treatment of Wet AMD
2024-05-15 17:00U:OTLKNews ReleaseOutlook Therapeutics(TM) Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
2024-05-13 08:50U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
2024-05-09 08:45U:OTLKNews ReleaseOutlook Therapeutics(TM) to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast
2024-05-02 09:05U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the Retina World Congress 2024
2024-04-29 09:00U:OTLKNews ReleaseOutlook Therapeutics(TM) to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
2024-04-15 16:15U:OTLKNews ReleaseOutlook Therapeutics(TM) Announces Closing of Private Placement of $5.0 Million